Format

Send to

Choose Destination
J Infect Dis. 2016 Nov 1;214(9):1421-1429. Epub 2016 Aug 19.

The Global Regulon sarA Regulates β-Lactam Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus In Vitro and in Endovascular Infections.

Author information

1
Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center.
2
Dartmouth Medical School, Hanover, New Hampshire.
3
Division of Infectious Diseases.
4
David Geffen School of Medicine at UCLA, Los Angeles, California.
5
Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark.
6
Division of Molecular Medicine, Los Angeles County-Harbor-UCLA Medical Center, Torrance.

Abstract

BACKGROUND:

 The global regulator sarA modulates virulence of methicillin-resistant Staphylococcus aureus (MRSA) via regulation of principal virulence factors (eg, adhesins and toxins) and biofilm formation. Resistance of S. aureus strains to β-lactam antibiotics (eg, oxacillin) depends on the production of penicillin-binding protein 2a (PBP2a), encoded by mecA METHODS:  In the present study, we investigated the impact of sarA on the phenotypic and genotypic characteristics of oxacillin resistance both in vitro and in an experimental endocarditis model, using prototypic healthcare- and community-associated MRSA parental and their respective sarA mutant strain sets.

RESULTS:

 All sarA mutants (vs respective MRSA parental controls) displayed significant reductions in oxacillin resistance and biofilm formation in vitro and oxacillin persistence in an experimental endocarditis model in vivo. These phenotypes corresponded to reduced mecA expression and PBP2a production and an interdependency of sarA and sigB regulators. Moreover, RNA sequencing analyses showed that sarA mutants exhibited significantly increased levels of primary extracellular proteases and suppressed pyrimidine biosynthetic pathway, argininosuccinate lyase-encoding, and ABC transporter-related genes as compared to the parental strain.

CONCLUSIONS:

 These results suggested that sarA regulates oxacillin resistance in mecA-positive MRSA. Thus, abrogation of this regulator represents an attractive and novel drug target to potentiate efficacy of existing antibiotic for MRSA therapy.

KEYWORDS:

MRSA endocarditis; sarA; treatment; β-lactam antibiotic resistance

PMID:
27543672
PMCID:
PMC5079373
DOI:
10.1093/infdis/jiw386
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center